Soleus Capital Management, L.P. Organogenesis Holdings Inc. Transaction History
Soleus Capital Management, L.P.
- $1.64 Billion
- Q3 2025
A detailed history of Soleus Capital Management, L.P. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 12,131,699 shares of ORGO stock, worth $55 Million. This represents 3.34% of its overall portfolio holdings.
Number of Shares
12,131,699
Previous 12,343,351
1.71%
Holding current value
$55 Million
Previous $45.2 Million
21.65%
% of portfolio
3.34%
Previous 3.5%
Shares
17 transactions
Others Institutions Holding ORGO
# of Institutions
126Shares Held
69.1MCall Options Held
39.7KPut Options Held
25-
Morgan Stanley New York, NY11.8MShares$53.4 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN7.5MShares$34 Million4.08% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$22.8 Million0.0% of portfolio
-
Assenagon Asset Management S.A.4.85MShares$22 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...